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Editors: Anton N. Sidawy and Bruce A. PerlerEndovascular aneurysm repair in nonagenarians is safe and effective
Lee J. Goldstein, Joshua A. Halpern, Combiz Rezayat, Katherine A.
Gallagher, Elliot B. Sambol, Harry L. Bush Jr, John K. Karwowski
Objectives: Advanced age is a significant risk factor that has traditionally
steered patients away from open aneurysm repair and toward expectant
management. Today, however, the reduced morbidity and mortality of aortic
stent grafting has created a new opportunity for aneurysm repair in patients
previously considered too high a risk for open surgery. Here we report our
experience with endovascular aneurysm repair (EVAR) in nonagenarians.
Methods: Retrospective chart review identified all patients >90-years-old
undergoing EVAR over a 9-year period at our institution. Collected data
included preoperative comorbidities, perioperative complications, endo-
leaks, reinterventions, and long-term survival.
Results: 24 patients underwent EVAR. Themean agewas 91.5 years (range 90-
94) among 15 (63%) males and 9 (37%) females. Mean abdominal aortic aneu-
rysm diameter was 6.3 1.1 cm. Eight patients (33%) were symptomatic (pain
or tenderness). There were no ruptures. Fourteen patients (58%) had general
anesthesiawhile 10 (42%) had local or regional anesthesia.Mean postoperative
length of stay was 3.2 2.4 days (2.8 1.9 days for asymptomatic vs 4.1 3.2
days for symptomatic, P = .29). There was one perioperative mortality (4.2%).
There were two local groin seromas (8.3%) and six systemic complications
(25%). One patient required reintervention for endoleak (4.2%). There were
no aneurysm related deaths beyond the 30-day postoperative period. Mean
survival beyond 30 days was 29.7  18.0 months for patients expiring during
follow-up. Cumulative estimated 12, 24, and 36-month survival rates were
83%, 64%, and 50%, respectively. Linear regression analysis demonstrated an
inverse relationship between the number of preoperative comorbidities and
postoperative survival in our cohort (R2 = 0.701), with significantly decreased
survival noted for patients presenting with >5 comorbidities. Those still alive
in follow-up have a mean survival of 36.1  16.0 months.
Conclusion: This is the largest reported EVAR series in nonagenarians.
Despite their advanced age, these patients benefit from EVAR with low
morbidity, low mortality, and mean survival exceeding 2.4 years. Survival
appears best in those patients with 5 comorbidities. With or without symp-
toms, patients over the age of 90 should be considered for EVAR.
Duplex ultrasound factors predicting persistent type II endoleak and
increasing AAA sac diameter after EVAR
Brian R. Beeman, Kathy Murtha, Kevin Doerr, Sandy McAfee-Bennett,
Matthew J. Dougherty, Keith D. Calligaro
Objective: While the significance of type II endoleaks (T2ELs) on the long-
term outcome of endovascular abdominal aneurysm repair (EVAR) to repair
abdominal aortic aneurysms (AAAs) is debatable, duplex ultrasonography
(DU) parameters have been suggested to be predictive of their closure or
persistence. The purpose of this study was to determine which, if any, of
these variables was associated with persistent T2EL or increased AAA sac
diameter.* Full articles available online at www.jvascsurg.org
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doi:10.1016/S1078-5884(10)00577-0Methods: Between 1998 and 2009, 278 patients underwent EVAR and post-
operative DU surveillance during long-term follow-up (1-11 years) in our ac-
credited non-invasive vascular laboratory by one of three experienced tech-
nologists. DU measured intra-sac flow velocity (IFV), spectral doppler
waveform (SDW) patterns, post-EVAR sac diameter, and number of T2ELs.
Results: T2ELs developed in 14% (38/278) of patients post-EVAR. Fourteen
patients had T2ELs that resolved, and sac diameter decreased or remained
the same: the average IFV was 42 cm/second; SDW patterns were monopha-
sic in five, biphasic in seven and bidirectional in two; and multiple T2ELs
were not present (0%) in any patient. Twelve patients had T2ELs that per-
sisted, but sac diameter decreased or remained the same: the average IFV
was 47 cm/second; SDW patterns were monophasic in one, biphasic in five,
bidirectional in five, and undetermined in one; and multiple T2ELs were
found in 17% (2) of patients. Twelve patients had T2ELs that persisted and
were associated with increased sac diameter: the average IFV was 43 cm/
second, SDW patterns were monophasic in one, biphasic in two, and bidirec-
tional in nine; and multiple T2ELs were identified in 75% (9) of patients.
None of the 38 patients with T2ELs treated with selective surgical or endo-
vascular intervention for enlarging sac diameters (11/12) experienced
a ruptured aneurysm.
Conclusion: Contrary to previous smaller reports of T2ELs and DU surveil-
lance, parameters such as IFV did not correlate with increased post-EVAR
sac diameter. The presence of multiple T2ELs and bidirectional SDW may
be the strongest factors predictive of increased sac diameter.Outcomes of planned celiac artery coverage during TEVAR
Manish Mehta, R. Clement Darling, John B. Taggert, Sean P. Roddy, Yaron
Sternbach, Kathleen J. Ozsvath, Paul B. Kreienberg, Philip S.K. Paty
Objective: Successful thoracic endovascular aneurysm repair (TEVAR)
requires adequate proximal and distal fixation and seal. We report our expe-
rience of planned celiac artery coverage during endovascular repair of
complex thoracic aortic aneurysms (TAA).
Methods: Since 2004, 228 patients underwent TEVAR under elective (n =
162, 71%) and emergent circumstances (66, 29%). Patients with inadequate
distal stent grafts landing zones during TEVAR underwent detailed evalua-
tion of the gastroduodenal arcade with communicating collaterals between
the celiac and superior mesenteric artery (SMA) by computed tomography
angiography and intraoperative arteriogram. If needed, in presence of
a patent SMA and demonstration of collaterals to the celiac artery, the stent
grafts were extended to the SMA with celiac artery coverage. Furthermore,
instances when further lengthening of distal thoracic stent graft landing
zone was needed to obtain an adequate seal, the SMA was partially covered
with the endograft, and a balloon expandable stent was routinely deployed
in proximal SMA to maintain patency. Outcome data were prospectively
collected and analyzed retrospectively.
Results: Thirty-one of 228 (14%) patients with TEVAR required celiac artery
interruption; 24 (77%) had demonstrable collaterals to the SMA. Twelve (39%)
of 31 patients underwent additional partial SMA coverage by stent graft, and
proximal SMA stent. The majority of patients were females (n = 20, 65%), the
mean age was 74 years (range 55-87 years), and the mean TAA size was 6.5 cm.
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paraplegia in 2 (6%) patients, and death in 2 (6%) patients. All type 1b endo-
leaks (n = 2, 6%) and type 2 endoleaks vial retrograde flow from the celiac
artery (n = 3, 10%) were successfully treated by transfemoral coil emboliza-
tion. Over a mean follow-up of 15 months, there have been no other compli-
cations of mesenteric ischemia, spinal cord ischemia, SMA in-stent stenosis,
or conversion to open surgical repair.
Conclusions: Our findings suggest that celiac artery coverage to facilitate
adequate distal sealing during TEVAR with complex TAA is relatively safe
in the presence of SMA-celiac collaterals. Pre-existing SMA stenosis can be
successfully treated by balloon expandable stents during TEVAR, and endo-
leaks arising from distal stent grafts attachment site or via retrograde flow
from the celiac artery can be successfully managed by transfemoral coil
embolization. Although early results are encouraging, long-term efficacy
of these procedures remains to be determined and vigilant follow-up is
needed.Lessons learned from the analysis of gender effect on risk factors and
procedural outcomes of lower extremity arterial disease
Ageliki G. Vouyouka, Natalia N. Egorova, Alexander Salloum, Lawrence
Kleinman, Michael Marin, Peter L. Faries, Allan Moscowitz
Introduction: Despite overall improvement, there is still a gender-related
disparity in the outcomes of lower extremities peripheral arterial disease
(PAD). We analyzed sex-related variability among factors that are known
to influence outcomes.
Methods: Data on PAD inpatient hospitalizations from New York, New
Jersey, and Florida state hospital discharge databases (1998-2007) were
analyzed using univariate and multivariate logistic regression analyses.
Results: Of the 372,692 surgical hospitalizations identified, 162,730 (43.66%)
involved women. Men and women undergoing vascular procedures differed
in that more men smoked (18% vs 14%, P < .0001), and more men had coro-
nary artery disease (40% vs 33%, P < .0001). Women were more likely to be
obese (11.86% vs 4.89%; P <.0001), black (18.81% vs 12.66%; P < .0001), old-
er, and have critical limb ischemia (CLI) (39.41% vs 37.67%; P < .0001). They
had higher mortality (5.26% vs 4.21%; P < .0001) and complication rates,
especially bleeding (10.62 % vs 8.19%; P < .0001) and infection (3.23% vs
2.88%; P < .0001). Mortality rates after endovascular procedures were lower
and showed marginal difference between genders (2.87% vs 2.11%; P <
.0001). The difference was more pronounced after open revascularizations
(5.05% for women vs 4.00% for men; P <.0001) and amputations (9.82% for
women vs 8.82% for men; P < .0001). Bleeding differences between men
and women were greatest when both open and endovascular procedures
were done during the same hospitalizations and lowest after major amputa-
tions. Similar to bleeding, transgender differences in postoperative infec-
tions were more pronounced after combination of open and endovascular
procedures. Using a multivariable model, female gender remained
a predictor of perioperative mortality, infection, and bleeding after vascular
intervention (odds ratios 1.15, 1.21, and 1.32, respectively). Female gender
negatively influenced the mortality of patients with cerebrovascular and
coronary disease and those of black race even after adjusting for relevant
clinical and demographic risk factors. Gender effect on mortality dissipated
in octogenarians and patients with claudication.
Conclusion: Female gender continues to be an important risk factor that
negatively influences the outcomes of vascular interventions; however,
these effects vary between different high-risk groups and procedures.
Gender effect on mortality dissipates in elderly patients. Prompt recognition
of the associations between gender and various risk factors of cardiovascular
disease and aggressive modification of these risk factors in female patients
may improve gender-related disparity in the outcomes of vascular disease.Prospective randomized trial comparing endovenous laser ablation and
surgery for treatment of primary great saphenous varicose veins with
a 2-year follow-up
Jan T. Christenson, Salah Gueddi, Gino Gemayel, Henri Bounameaux
Background: Endovenous laser therapy (EVLT) for ablation of the great
saphenous vein (GSV) is thought to minimize postoperative morbidity
compared with high ligation and stripping (HL/S). Only a few randomizedtrials have reported early results. This prospective randomized trial compared
EVLT (980 nm) and HL/S results at 1 and 2 years after the intervention.
Method: Patients with symptomatic varicose veins due to GSV insufficiency
were randomized to HL/S (100 limbs) or EVLT (104 limbs). Four EVLT proce-
dures failed primarily and were excluded. Phlebectomy and ligature of
incompetent perforators were performed whenever indicated in both
groups. Patients were re-examined clinically and by duplex ultrasound
imaging preoperatively and at 12 days and at 1 and 2 years after treatment.
Closure rate, complication rate, time to return to normal activity, the
Aberdeen Varicose Vein Symptom Severity Score (AVVSS), the Varicose
Venous Clinical Severity Score (VVCSS), and the Medical Outcome Study
Short Form-36 scores were also recorded.
Results: There were no differences in patient demographics, CEAP class,
Widmer class, or severity scores between the groups. Simultaneous interven-
tions did not differ between the groups. Similar times for the return to
normal activity and scores for postoperative pain were reported. No major
complications after treatment were recorded. HL/S limbs had significantly
more postoperative hematomas than EVLT limbs, and EVLT patients reported
more bruising. Follow-up at 1 year was 100% for HL/S and 99% for EVLT. Two
GSVs in the EVLT group reopened and three partially reopened. No open
GSVs occurred in HL/S limbs. Ninety-eight percent of the limbs in both
groups were free of symptoms. VCSS, AVVSS, and Short Form-36 scores did
not reveal any group differences. At 2 years, no differences compared with
1-year results were observed, except that two more GSVs in the EVLT group
were partially reopened.
Conclusions: Abolition of GSV reflux and improvement in quality of life was
similar after HL/S and EVLT. After EVLT, however, two GSVs were found
completely reopened and five were partially reopened, which was signifi-
cantly higher than after HL/S. A prolonged follow-up is ongoing.
Therapy of isolated calf muscle vein thrombosis. A randomized,
controlled study
Thomas Schwarz, Lutz Buschmann, Jan Beyer, Kai Halbritter, Aljosha Rastan,
Sebastian Schellong
Background: Treatment of isolated calf muscle vein thrombosis (ICMVT) is
controversial. There is no data from prospective, controlled studies. Objec-
tive of this article was to compare the efficacy and safety of a short-term
course of anticoagulation with compression therapy alone.
Methods: We prospectively randomized patients with symptomatic, sono-
graphically proven isolated calf muscle vein thrombosis in the soleal and/
or gastrocnemial muscle veins in two treatment arms. The first received
low-molecular-weight heparin for 10 days at therapeutic dosage (nadroparin
180 anti-activated factor X units once daily) and compression therapy for
three months, and the second received compression therapy alone. Primary
efficacy endpoint of the study was sonographically proven progression of
ICMVT into the deep veins and clinical pulmonary embolism (PE) as
confirmed by objective testing. Secondary efficacy and primary
safety endpoints were major bleeding, death not due to pulmonary embo-
lism, and complete sonographically proven recanalization of the muscle
vein. We assessed transient and permanent risk factors for venous
thromboembolism.
Results: One-hundred seven patients were finally ruled eligible for evalua-
tion: 89% outpatients, 11% hospitalized patients. In the heparin group (n =
54) progression to deep vein thrombosis (DVT) occurred in two patients
(3.7%), in the group compression therapy alone (n = 53) progression to DVT
occurred in two patients (n.s.). No clinical pulmonary embolism and no
death occurred. Thrombus recanalization after 3 months was not statisti-
cally significant different between the two study groups. No major bleeding
occurred.
Conclusion: Data does not show superiority of a short-term regimen of low-
molecular-weight heparin and compression therapy in comparison with
compression therapy alone in patients with isolated calf muscle vein throm-
bosis in a rather low-risk population.
Sourcing of superficial reflux in venous leg ulcers using duplex ultrasound
Alfred Obermayer, Katharina Garzon
Objective: Mapping of venous reflux routes associated with medially or
laterally located venous leg ulcers and their source of origin.
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tions performed in consecutive leg ulcer patients, all with venous reflux,
in a time period over 2 years. A total of 169 patients (183 legs), with chronic
venous leg ulcers (CEAP: C6) were examined in a private practice. The data
collection integrated an examination that included medical history and clin-
ical diagnoses and incorporated measurements such as body mass index, os-
cillometric index, and range of motion of the ankle joint. Venous function
was assessed with duplex ultrasound, and the cases were described using
the advanced CEAP classification. Additionally, a ‘‘sourcing’’ technique
was performed with duplex ultrasound investigation of the ulcer bed and
the venous system under manual compression and release of the ulcer.
The principle of ‘‘sourcing’’ is to follow venous reflux from the ulcer area
to its proximal origin. The detected reflux routes were classified either as
‘‘axial’’ or ‘‘crossover’’ type.
Results: A total of 20% of the ulcer patients showed no clinically visible vari-
cose veins. One hundred three patients had medial ulcers, 54 lateral ulcers,
21 medial and lateral, and five had gaiter ulcers. Sixty-four (35%) of the medi-
ally located ulcers had reflux in the great saphenous vein (GSV), 28 (15%)
showed reflux in the medial perforating veins (axial types), and 11 (6%)
had reflux in the small saphenous vein (SSV; crossover type). From 54 patients
presenting with lateral ulcers, 25 (14%) showed GSV incompetence (crossover
type) and only 13 (7%) SSV incompetence (axial type). Sixteen patients
showed refluxes penetrating from deep into lateral perforating veins.Conclusion: Crossover reflux routes were detected in 25 of 54 (46%) legs
with lateral and in 11 of 103 (11%) legs with medial ulceration (c2 44.34; P
< .001). In venous ulcer patients, an extended examination (CEAP classifica-
tion) and a special duplex technique (‘‘sourcing’’) are recommended to
identify the specific route responsible for the venous reflux. This seems
essential for planning a rational treatment of venous reflux ulcers.Superficialization of arteriovenous fistulas employing minimally invasive
liposuction
Marlin Wayne Causey, Reagan Quan, Adam Hamawy, Niten Singh
Superficialization of arteriovenous fistulas allows for improved dialysis
access allowing for prolonged utilization and more efficient dialysis treat-
ment. Multiple methods are described for superficializing arteriovenous
fistulas, and minimizing the surgical intervention is advantageous for patient
recovery and potentially improved outcomes. We describe a novel technique
of superficialization of an upper extremity arteriovenous fistula employing
ultrasound-guided liposuction. This article describes the suction lipectomy
technique and the tools necessary for superficialization of an upper
extremity arteriovenous fistula.
